Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rössner

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Mutation Research|July 1, 1988
Effect of ascorbic acid prophylaxis on the frequency of chromosome aberrations, urine mutagenicity and nucleolus test in workers occupationally exposed to cytostatic drugsP Rössner, M Cerná, D Pokorná, et al.
Psychophysiology|April 9, 1999
Event-related potential correlates of proactive interference in schizophrenic patients and controlsP Rössner, B Rockstroh, R Cohen, et al.
Mutation Research|November 18, 2000
The effect of dibenzo[a,1]pyrene and benzo[a]pyrene on human diploid lung fibroblasts: the induction of DNA adducts, expression of p53 and p21(WAF1) proteins and cell cycle distributionB Binková, Y Giguère, P Rössner, et al.
Mutation Research|May 1, 1983
Effect of ascorbic acid prophylaxis on the frequency of chromosome aberrations in the peripheral lymphocytes of coal-tar workersR J Srám, L Dobiás, A Pastorková, et al.
Mutation Research|June 13, 1997
The use of a urine mutagenicity assay in the monitoring of environmental exposure to genotoxinsM Cerná, A Pastorková, S R Myers, et al.
Toxicology Letters|August 23, 2002
Chromosomal aberrations in peripheral lymphocytes of children as biomarkers of environmental exposure and life styleP Rössner, H Bavorova, D Ocadlikova, et al.
Mutation Research|January 1, 1980
Mutagenicity studies with nitrofurans. III. Mutagenicity testing of nitrofurylacrylic acid in human blood and urineM Cerná, P Rössner, K Angelis, et al.
Ceskoslovenska Farmacie|May 1, 1990
[Mutagenic activity analysis of body fluids in the first phase of clinical drug trials]M Cerná, L Dobiás, V Hájek, et al.
Maturitas|April 2, 1998
A comparative study of two levonorgestrel-containing hormone replacement therapy regimens of efficacy and tolerability variablesT Gräser, P Rössner, K Schubert, et al.
The Science of the Total Environment|January 1, 1991
Environmental genotoxicity monitoring using Salmonella typhimurium strains as indicator systemN Cerná, V Hájek, E Stejskalová, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Mutation Research|July 1, 1988
Effect of ascorbic acid prophylaxis on the frequency of chromosome aberrations, urine mutagenicity and nucleolus test in workers occupationally exposed to cytostatic drugsP Rössner, M Cerná, D Pokorná, et al.
Psychophysiology|April 9, 1999
Event-related potential correlates of proactive interference in schizophrenic patients and controlsP Rössner, B Rockstroh, R Cohen, et al.
Mutation Research|November 18, 2000
The effect of dibenzo[a,1]pyrene and benzo[a]pyrene on human diploid lung fibroblasts: the induction of DNA adducts, expression of p53 and p21(WAF1) proteins and cell cycle distributionB Binková, Y Giguère, P Rössner, et al.
Mutation Research|May 1, 1983
Effect of ascorbic acid prophylaxis on the frequency of chromosome aberrations in the peripheral lymphocytes of coal-tar workersR J Srám, L Dobiás, A Pastorková, et al.
Mutation Research|June 13, 1997
The use of a urine mutagenicity assay in the monitoring of environmental exposure to genotoxinsM Cerná, A Pastorková, S R Myers, et al.
Toxicology Letters|August 23, 2002
Chromosomal aberrations in peripheral lymphocytes of children as biomarkers of environmental exposure and life styleP Rössner, H Bavorova, D Ocadlikova, et al.
Mutation Research|January 1, 1980
Mutagenicity studies with nitrofurans. III. Mutagenicity testing of nitrofurylacrylic acid in human blood and urineM Cerná, P Rössner, K Angelis, et al.
Ceskoslovenska Farmacie|May 1, 1990
[Mutagenic activity analysis of body fluids in the first phase of clinical drug trials]M Cerná, L Dobiás, V Hájek, et al.
Maturitas|April 2, 1998
A comparative study of two levonorgestrel-containing hormone replacement therapy regimens of efficacy and tolerability variablesT Gräser, P Rössner, K Schubert, et al.
The Science of the Total Environment|January 1, 1991
Environmental genotoxicity monitoring using Salmonella typhimurium strains as indicator systemN Cerná, V Hájek, E Stejskalová, et al.
Pageof 5